Xtl Biopharmaceuticals (XTLB) EBT Margin (QoQ) (2011 - 2018)
Xtl Biopharmaceuticals (XTLB) EBT Margin (QoQ) (2011 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 0.00 |
| Sep 30, 2017 | -3,699.00 |
| Jun 30, 2017 | 34,404.00 |
| Sep 30, 2014 | -1,107.00 |
| Jun 30, 2014 | -28,889.00 |
| Mar 31, 2014 | 62,427.00 |
| Dec 31, 2013 | -48,396.00 |
| Sep 30, 2013 | -4,159.00 |
| Jun 30, 2013 | -426.00 |
| Mar 31, 2013 | 8,052.00 |
| Dec 31, 2012 | -2,921.00 |
| Sep 30, 2012 | 10,385.00 |
| Jun 30, 2012 | -17,890.00 |
| Mar 31, 2012 | 6,061.00 |
| Dec 31, 2011 | 8,470.00 |
| Sep 30, 2011 | -4,620.00 |